Market Research Logo

Melinta Therapeutics, Inc - Product Pipeline Review - 2016

Table of Contents
List of Tables
List of Figures
Melinta Therapeutics, Inc Snapshot
Melinta Therapeutics, Inc Overview
Key Information
Key Facts
Melinta Therapeutics, Inc - Research and Development Overview
Key Therapeutic Areas
Melinta Therapeutics, Inc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Melinta Therapeutics, Inc - Pipeline Products Glance
Melinta Therapeutics, Inc - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Melinta Therapeutics, Inc - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Melinta Therapeutics, Inc - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Melinta Therapeutics, Inc - Drug Profiles
delafloxacin
Product Description
Mechanism of Action
R&D Progress
radezolid
Product Description
Mechanism of Action
R&D Progress
RX-02
Product Description
Mechanism of Action
R&D Progress
RX-04
Product Description
Mechanism of Action
R&D Progress
RX-05
Product Description
Mechanism of Action
R&D Progress
RXP-792
Product Description
Mechanism of Action
R&D Progress
RXP-873
Product Description
Mechanism of Action
R&D Progress
RXP-763
Product Description
Mechanism of Action
R&D Progress
RXP-766
Product Description
Mechanism of Action
R&D Progress
RXP-770
Product Description
Mechanism of Action
R&D Progress
RXP-793
Product Description
Mechanism of Action
R&D Progress
RXP-808
Product Description
Mechanism of Action
R&D Progress
Melinta Therapeutics, Inc - Pipeline Analysis
Melinta Therapeutics, Inc - Pipeline Products by Target
Melinta Therapeutics, Inc - Pipeline Products by Route of Administration
Melinta Therapeutics, Inc - Pipeline Products by Molecule Type
Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action
Melinta Therapeutics, Inc - Recent Pipeline Updates
Melinta Therapeutics, Inc - Dormant Projects
Melinta Therapeutics, Inc - Company Statement
Melinta Therapeutics, Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Melinta Therapeutics, Inc, Key Information
Melinta Therapeutics, Inc, Key Facts
Melinta Therapeutics, Inc - Pipeline by Indication, 2016
Melinta Therapeutics, Inc - Pipeline by Stage of Development, 2016
Melinta Therapeutics, Inc - Monotherapy Products in Pipeline, 2016
Melinta Therapeutics, Inc - Phase III, 2016
Melinta Therapeutics, Inc - Phase II, 2016
Melinta Therapeutics, Inc - Preclinical, 2016
Melinta Therapeutics, Inc - Discovery, 2016
Melinta Therapeutics, Inc - Pipeline by Target, 2016
Melinta Therapeutics, Inc - Pipeline by Route of Administration, 2016
Melinta Therapeutics, Inc - Pipeline by Molecule Type, 2016
Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action, 2016
Melinta Therapeutics, Inc - Recent Pipeline Updates, 2016
Melinta Therapeutics, Inc - Dormant Developmental Projects,2016
Melinta Therapeutics, Inc, Other Locations
List of Figures
Melinta Therapeutics, Inc - Pipeline by Top 10 Indication, 2016
Melinta Therapeutics, Inc - Pipeline by Stage of Development, 2016
Melinta Therapeutics, Inc - Monotherapy Products in Pipeline, 2016
Melinta Therapeutics, Inc - Pipeline by Target, 2016
Melinta Therapeutics, Inc - Pipeline by Route of Administration, 2016
Melinta Therapeutics, Inc - Pipeline by Molecule Type, 2016
Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action, 2016

Melinta Therapeutics, Inc - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Melinta Therapeutics, Inc - Product Pipeline Review - 2016’, provides an overview of the Melinta Therapeutics, Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Melinta Therapeutics, Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Melinta Therapeutics, Inc
The report provides overview of Melinta Therapeutics, Inc including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Melinta Therapeutics, Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Melinta Therapeutics, Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Melinta Therapeutics, Inc’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Melinta Therapeutics, Inc
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Melinta Therapeutics, Inc’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;